Skip to content

Clinical trials

Recruiting Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Status: Recruiting Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20191
20201
20214
20223
202311
202411
202516
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
DualityBio Inc.2
Fudan University2
A2 Biotherapeutics Inc.1
AP Biosciences Inc.1
Akeso1
Alentis Therapeutics AG1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Aulos Bioscience, Inc.1
Beijing Biotech1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck56
Carcinoma, Non-Small-Cell Lung25
Melanoma14
Triple Negative Breast Neoplasms14
Uterine Cervical Neoplasms14
Carcinoma, Renal Cell11
Head and Neck Neoplasms11
Neoplasm Metastasis11
Colorectal Neoplasms10
Endometrial Neoplasms10

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.